Table 2.

Demographic parameters of studied group.

Parameter	Value
Number of patients, n	53
Females, n (%)	21 (39.6%)
Males, n (%)	32 (60.4%)
Mean age, years ±SD	63.2±10.2
BMI, kg/m2 ±SD	25.1±4.5
ASA 1, n (%)	1 (1.9%)
ASA 2, n (%)	36 (67.9%)
ASA 3, n (%)	16 (30.2%)
Neoadjuvant chemotherapy, n (%)	32 (60.4%)
AJCC Stage 0, n (%)	1 (1.9%)
AJCC Stage Ia, n (%)	5 (9.4%)
AJCC Stage Ib, n (%)	8 (15.1%)
AJCC Stage IIa, n (%)	7 (13.2%)
AJCC Stage IIb, n (%)	6 (11.3%)
AJCC Stage IIIa, n (%)	7 (13.2%)
AJCC Stage IIIb, n (%)	11 (20.8%)
AJCC Stage IIIc, n (%)	7 (13.2%)
AJCC Stage IV, n (%)	1 (1.9%)